chr5-178143949-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022762.5(RMND5B):c.535G>A(p.Val179Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,152 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022762.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RMND5B | NM_022762.5 | c.535G>A | p.Val179Ile | missense_variant | 7/11 | ENST00000313386.9 | NP_073599.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RMND5B | ENST00000313386.9 | c.535G>A | p.Val179Ile | missense_variant | 7/11 | 1 | NM_022762.5 | ENSP00000320623 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000172 AC: 43AN: 250626Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135570
GnomAD4 exome AF: 0.000124 AC: 181AN: 1461802Hom.: 1 Cov.: 32 AF XY: 0.000146 AC XY: 106AN XY: 727200
GnomAD4 genome AF: 0.000171 AC: 26AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74510
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2023 | The c.535G>A (p.V179I) alteration is located in exon 7 (coding exon 5) of the RMND5B gene. This alteration results from a G to A substitution at nucleotide position 535, causing the valine (V) at amino acid position 179 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at